This event is not ran by the Coventry and Warwickshire Training Hub.
This is a promotional meeting supported and funded by A.Menarini Farmaceutica Internazionale SRL including honoraria in accordance with the ABPI code of practice.
This meeting is for UK registered HCPs only.
KEY TAKEAWAYS:
- * Optimising glycaemic control is still important, especially early in type 2 diabetes and to achieve “legacy effect” identified by the UK Prospective Diabetes Study
- * Early blood glucose control for people with T2D is crucial for reducing cardiovascular and renal complications
- * Approach to glycaemic control is two pronged from addressing the causes of clinical inertia and tackling treatment adherence
- * Treatment guidelines which support using more than one glucose-lowering therapy to achieve glycaemic control